These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 30280953)
1. Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles. You Q; Hopf T; Hintz W; Rannabauer S; Voigt N; van Wachem B; Henrich-Noack P; Sabel BA J Drug Target; 2019 Mar; 27(3):338-346. PubMed ID: 30280953 [TBL] [Abstract][Full Text] [Related]
2. How Nanoparticle Physicochemical Parameters Affect Drug Delivery to Cells in the Retina via Systemic Interactions. You Q; Sokolov M; Grigartzik L; Hintz W; van Wachem BGM; Henrich-Noack P; Sabel BA Mol Pharm; 2019 Dec; 16(12):5068-5075. PubMed ID: 31609624 [TBL] [Abstract][Full Text] [Related]
3. Surfactants, not size or zeta-potential influence blood-brain barrier passage of polymeric nanoparticles. Voigt N; Henrich-Noack P; Kockentiedt S; Hintz W; Tomas J; Sabel BA Eur J Pharm Biopharm; 2014 May; 87(1):19-29. PubMed ID: 24607790 [TBL] [Abstract][Full Text] [Related]
4. In vivo visualisation of nanoparticle entry into central nervous system tissue. Henrich-Noack P; Prilloff S; Voigt N; Jin J; Hintz W; Tomas J; Sabel BA Arch Toxicol; 2012 Jul; 86(7):1099-105. PubMed ID: 22422342 [TBL] [Abstract][Full Text] [Related]
5. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Kuo YC; Su FL Int J Pharm; 2007 Aug; 340(1-2):143-52. PubMed ID: 17418986 [TBL] [Abstract][Full Text] [Related]
6. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation. Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205 [TBL] [Abstract][Full Text] [Related]
7. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier. Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104 [TBL] [Abstract][Full Text] [Related]
8. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity. Rempe R; Cramer S; Hüwel S; Galla HJ Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549 [TBL] [Abstract][Full Text] [Related]
9. Polybutylcyanoacrylate nanoparticles as novel vectors in cancer gene therapy. Zhang Y; Zhang Y; Chen J; Zhang B; Pan Y; Ren L; Zhao J; Luo Y; Zhai D; Wang S; Wang J Nanomedicine; 2007 Jun; 3(2):144-53. PubMed ID: 17468053 [TBL] [Abstract][Full Text] [Related]
10. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Kuo YC; Chen HH Int J Pharm; 2006 Dec; 327(1-2):160-9. PubMed ID: 16939704 [TBL] [Abstract][Full Text] [Related]
11. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles. Gao K; Jiang X Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779 [TBL] [Abstract][Full Text] [Related]
12. [Carrier-mediated Transport of Cationic Drugs across the Blood-Tissue Barrier]. Kubo Y Yakugaku Zasshi; 2015; 135(10):1135-40. PubMed ID: 26423869 [TBL] [Abstract][Full Text] [Related]
13. Effect of surfactant on fabrication and characterization of paclitaxel-loaded polybutylcyanoacrylate nanoparticulate delivery systems. Mitra A; Lin S J Pharm Pharmacol; 2003 Jul; 55(7):895-902. PubMed ID: 12906746 [TBL] [Abstract][Full Text] [Related]
14. Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells. Kuo YC; Chung CY Colloids Surf B Biointerfaces; 2012 Mar; 91():242-9. PubMed ID: 22137614 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles. Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984 [TBL] [Abstract][Full Text] [Related]
16. The Effect of Polybutylcyanoacrylate Nanoparticles as a Protos Delivery Vehicle on Dental Bone Formation. Chang LC; Chung CY; Chiu CH; Lin MH; Yang JT Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062952 [TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles. Zhang Y; Yu J; Zhang L; Cai J; Cai D; Lv C Tumour Biol; 2016 Feb; 37(2):2703-8. PubMed ID: 26404136 [TBL] [Abstract][Full Text] [Related]
18. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles. Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943 [TBL] [Abstract][Full Text] [Related]
19. [Preparation of paclitaxel-loaded polybutylcyanoacrylate nanoparticles]. Chen RD; Ren F; Li GF; Liu SJ Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):763-6. PubMed ID: 20423845 [TBL] [Abstract][Full Text] [Related]
20. Poly(n-butylcyanoacrylate) nanoparticles for oral delivery of quercetin: preparation, characterization, and pharmacokinetics and biodistribution studies in Wistar rats. Bagad M; Khan ZA Int J Nanomedicine; 2015; 10():3921-35. PubMed ID: 26089668 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]